| Filed On | Filing |
|---|---|
| 13 Nov 2026 |
Form 4: Maunsell Farris Maryanne, VP, Chief Accounting Officer
Received 2,146 shares by exercise or conversion ($187K) · Gave up 1,724 shares to cover exercise price or tax ($209K) · Sold 836 shares ($101K) |
| 12 Nov 2026 | 144 |
| 05 Nov 2026 | 10-Q |
| 05 Nov 2026 |
8-K: Results of Operations and Financial Condition
Boston, MA, November 5, 2026 - Haemonetics Corporation (NYSE: HAE) reported financial results for its second quarter of fiscal 2027, which ended September 26, 2026: |
| 03 Nov 2026 |
Form 4: Galvin Roy, EVP, Chief Commercial Officer
Gave up 146 shares to cover exercise price or tax ($17.5K) |
| 08 Oct 2026 |
8-K: Regulation FD Disclosure
On August 18, 2026, Haemonetics Corporation (the “Company”) furnished a Current Report on Form 8-K disclosing its entry into a non-exclusive supply agreement with CSL Plasma Inc. (“CSL”), under which CSL may utilize the Company’s NexSys ... |
| 18 Aug 2026 |
8-K: Regulation FD Disclosure
On August 14, 2026, Haemonetics Corporation (the “Company”) entered into a supply agreement with CSL Plasma Inc. (“CSL”) pursuant to which CSL may utilize the Company’s NexSys PCS® devices with Persona® PLUS technology and purchase relat... |
| 12 Aug 2026 | SCHEDULE 13G/A |
| 06 Aug 2026 | S-8 |
| 06 Aug 2026 | 10-Q |
| 06 Aug 2026 |
8-K: Results of Operations and Financial Condition
Boston, MA, August 6, 2026 - Haemonetics Corporation (NYSE: HAE) reported financial results for its first quarter of fiscal 2027, which ended June 27, 2026: |
| 28 Jul 2026 |
Form 4: Madaus Martin D, Director
Received 2,538 shares as a grant or award |
| 28 Jul 2026 |
Form 4: Zane Ellen M, Director
Received 2,538 shares as a grant or award |
| 28 Jul 2026 |
Form 4: Pomeroy Claire, Director
Received 2,538 shares as a grant or award |
| 28 Jul 2026 |
Form 4: Kroll Mark W, Director
Received 2,538 shares as a grant or award |
| 28 Jul 2026 |
Form 4: Johnson Lloyd Emerson, Director
Received 2,538 shares as a grant or award |
| 28 Jul 2026 |
Form 4: Coyle Michael J, Director
Received 2,538 shares as a grant or award |
| 28 Jul 2026 |
Form 4: Bryant Diane M, Director
Received 2,538 shares as a grant or award |
| 28 Jul 2026 |
Form 4: Abernathy Robert E, Director
Received 2,538 shares as a grant or award |
| 28 Jul 2026 |
Form 3: Madaus Martin D, Director
No securities owned |
Loading...